Literature DB >> 26902545

Use of rapid needs assessment as a tool to identify vaccination delays in Guatemala and Peru.

Katie K D'Ardenne1, Juliana Darrow2, Anna Furniss3, Catia Chavez4, Herminio Hernandez5, Stephen Berman6, Edwin J Asturias7.   

Abstract

OBJECTIVE: To explore the use of rapid needs assessment (RNA) surveys to determine the prevalence and factors contributing to delays in vaccination of children in two low middle-income countries (LMIC).
METHODS: Data from two RNA surveys performed as part of program improvement evaluations in Guatemala and Peru were used for this analysis. The primary endpoint was the timeliness of immunization with delay defined as administration of vaccines beyond 28 days from recommended age for DTwP-HepB-Hib (Penta) and measles-mumps-rubella (MMR) vaccines, as well as past age-restrictions for rotavirus vaccine. Independent risk factors analyzed included child's gender, birth year, number of children in household, maternal age, maternal education, and food insecurity.
RESULTS: Vaccine information was available from 811 children from 838 households surveyed. High rate of immunization delays was observed, with 75.6% of children in Guatemala and 57.8% of children in Peru being delayed for the third dose of Penta primary series. Factors associated with delayed vaccination in Guatemala included advanced maternal age and increased number of children in household. In Peru, significant associations were birth year before 2009, lower maternal education level, and increased number of children in household.
CONCLUSIONS: RNA is a fast and effective method to identify timely vaccine coverage and derive a hypothesis of factors possibly associated with vaccination delay.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Guatemala; Immunization delays; Measles; Pentavalent; Peru; Rapid needs assessment; Rotavirus; Vaccines

Mesh:

Substances:

Year:  2016        PMID: 26902545     DOI: 10.1016/j.vaccine.2016.01.060

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Knowledge of Norovirus and Attitudes toward a Potential Norovirus Vaccine in Rural Guatemala: A Cross-Sectional Exploratory Survey.

Authors:  Daniel Olson; Steven Krager; Molly M Lamb; Anne-Marie Rick; Edwin J Asturias
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

2.  Rapid Active Sampling Surveys as a Tool to Evaluate Factors Associated with Acute Gastroenteritis and Norovirus Infection among Children in Rural Guatemala.

Authors:  Daniel Olson; Molly M Lamb; Maria R Lopez; Maria A Paniagua-Avila; Alma Zacarias; Gabriela Samayoa-Reyes; Celia Cordon-Rosales; Edwin J Asturias
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

3.  Performance of a Mobile Phone App-Based Participatory Syndromic Surveillance System for Acute Febrile Illness and Acute Gastroenteritis in Rural Guatemala.

Authors:  Daniel Olson; Molly Lamb; Maria Renee Lopez; Kathryn Colborn; Alejandra Paniagua-Avila; Alma Zacarias; Ricardo Zambrano-Perilla; Sergio Ricardo Rodríguez-Castro; Celia Cordon-Rosales; Edwin Jose Asturias
Journal:  J Med Internet Res       Date:  2017-11-09       Impact factor: 5.428

4.  A Rapid Epidemiological Tool to Measure the Burden of Norovirus Infection and Disease in Resource-Limited Settings.

Authors:  Daniel Olson; Molly M Lamb; Maria Renee Lopez; M Alejandra Paniagua-Avila; Alma Zacarias; Gabriela Samayoa-Reyes; Celia Cordon-Rosales; Edwin J Asturias
Journal:  Open Forum Infect Dis       Date:  2017-03-17       Impact factor: 3.835

5.  Vaccination timeliness and delay in low- and middle-income countries: a systematic review of the literature, 2007-2017.

Authors:  Nina B Masters; Abram L Wagner; Matthew L Boulton
Journal:  Hum Vaccin Immunother       Date:  2019-06-12       Impact factor: 3.452

6.  Descriptive analysis of routine childhood immunisation timeliness in the Western Cape, South Africa.

Authors:  Ntombifuthi Blose; Edina Amponsah-Dacosta; Benjamin M Kagina; Rudzani Muloiwa
Journal:  Vaccine X       Date:  2021-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.